Search Repository Universitas Fort De Kock

World Health Organization (WHO) tahun 2019 didapatkan jumlah kejadian mual dan muntah mencapai 12,5% dari seluruh jumlah kehamilan di dunia, mual dan muntah (Emesis Gravidarum) merupakan hal yang dihadapi ibu hamil selama periode trimester I, mulai dari mual muntah ringan sampai dengan berat, sehingga menyebabkan komplikasi kesehatan ibu diantaranya kekurangan cairan, nafsu makan menurun hingga anemia. Mual muntah dapat diatasi dengan terapi nonfarmakologi, salah satunya dengan seduhan jahe yang mengandung sifat anti-inflamasi, zat aktif gingerol dan shogaol yang menekan rasa mual dan muntah. Tujuan penelitian adalah untuk mengetahui frek mual muntah dan efektifitas seduhan jahe tehadap penurunan frekuensi mual muntah melalui tiga dosis pembanding. Metode Penelitian ini mengunakan Preeksperiment Design dengan rancangan pretest-posttest design dengan sampel sebanyak 30 orang, analisis data menggunakan uji paired sample t-test. Hasilnya untuk dosis 0,25 gram terjadi rata-rata penurunan mual muntah sebanyak 3,5 sedangkan untuk dosis 1gram rata-rata penurun tingkat mual muntah sebesar 4,2 , untuk pada dosis 2,5gram rata-rata penurunan tingkat mual muntah sebanyak 4,1. Seduhan ketiga jenis dosis jahe efektif dalam mengurangi tingkat mual muntah dengan p-value (p=0,000) untuk ketiga dosis. Kesimpulan bahwa terjadi pengaruh yang signifikan terhadap penurunan tingkat mual muntah dengan menggunakan ke tiga dosis seduhan jahe yang berbeda. Disarankan untuk mengkonsumsi seduhan jahe dengan dosis 1 gram karena memiliki tingkat rata-rata penurunan mual muntah yang lebih tinggi dari dosis yang lain.

In 2019, the World Health Organization (WHO) identified that approximately 12.5% of global pregnancies experienced episodes of nausea and vomiting. Nausea and vomiting, often referred to as Emesis Gravidarum, are common occurrences during the First Trimester of pregnancy. These symptoms can range from mild nausea to severe vomiting, potentially leading to health complications for expectant mothers. Such complications encompass issues like dehydration, diminished appetite, and even anemia. Non-pharmacological interventions, including ginger infusion, present viable strategies for managing and alleviating these symptoms. Ginger infusion contains anti-inflammatory properties and bioactive compounds such as gingerol and shogaol, known for their effectiveness in curbing nausea and vomiting. The primary objective of this study is to assess the frequency of nausea and vomiting during pregnancy, as well as to evaluate the efficacy of ginger infusion in reducing these symptoms. This evaluation is conducted through the consideration of three varying doses. The research methodology employs a pre-experimental design, specifically a pretest posttest design, utilizing a sample size of 30 individuals. Data analysis is performed utilizing a paired sample t-test. The results indicate noteworthy insights: for a dose of 0.25 grams, the average reduction in nausea and vomiting is 3.5; for a dose of 1 gram, the average reduction is 4.2; and for a dose of 2.5 grams, the average reduction is 4.1. All three doses of ginger infusion demonstrated effectiveness in diminishing the severity of nausea and vomiting, substantiated by a p-value of 0.000 for all three doses. In conclusion, the research underscores the significant impact of ginger infusion in reducing the intensity of nausea and vomiting during pregnancy. The findings suggest that a dose of 1 gram is particularly effective in achieving this reduction. It is advisable for pregnant women experiencing these symptoms to consider incorporating ginger infusion, particularly at the 1-gram dosage, into their management regimen.